Clinical trial
The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.
NCT00381420 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00381420 |
|---|---|
| Title | The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. |
| Official title | A Canadian Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Coated BX Velocity Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions. |
| Acronym | C-SIRIUS |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | drug-eluting stent, bare-metal stent |
| Enrollment | 100 |
| Start date | Mar 1, 2001 |
| Primary completion | Dec 1, 2002 |
| Completion | Jun 1, 2008 |
| First posted | Sep 27, 2006 |
| Last update posted | Oct 31, 2008 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: